MedTech Reimbursement Playbook
Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.
Resource Library
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
Filter By:
The End of Chevron Deference: What it Means for Medtech
The AdvaMed Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed China Code” or “Code” – serves as a foundational charter for medical technology companies’…
AdvaMed Code Of Ethics on Interactions With Health Care Professionals in China
The AdvaMed Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed China Code” or “Code” – serves as a foundational charter for medical technology companies’…
AdvaMed Medical Imaging Standards
AdvaMed creates industry standards and white papers relevant to medical imaging technology, including X-Ray, CT, Ultrasound, MR, and molecular imaging modalities.
2024 China Code of Ethics Implementation Tools
The AdvaMed Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed China Code” or “Code” – serves as a foundational charter for medical technology companies’…
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Racial and Ethnic Diversity in FDA Regulated Clinical Trials
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
PFAS in Medtech
Per- and polyfluoroalkyl substances, known as PFAS, are a broad class of over 12,000 substances that are found in a variety of consumer, commercial and industrial products, including medical devices…
Phase III: Disparities in Access to Selected Advanced Medical Procedures in the Medicare Population
The final report of a three-part series investigates the prevalence of racial and ethnic disparities in the use of in the use of advanced interventions in the Medicare program.